New registry aims to unlock secrets of rare skin disease GPP

NCT ID NCT06100991

Recruiting now Knowledge-focused Sponsor: CorEvitas Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a registry that will follow about 200 people with generalized pustular psoriasis (GPP) across North America. Researchers want to learn more about how GPP develops, how it is managed, and what happens to patients over time. Participants will be under the care of a dermatologist and will provide information about their condition and treatments. This is an observational study, meaning no new drugs or treatments are being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could provide valuable insights into how GPP behaves and is treated, potentially guiding future research and care.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may take years and might not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENERALIZED PUSTULAR PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

generalized pustular psoriasis psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GENERALIZED PUSTULAR PSORIASIS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

CorEvitas, LLC
RECRUITING

Waltham, Massachusetts, 02451, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.